FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049166118> ?p ?o ?g. }

• W2049166118 endingPage "557" @default.
• W2049166118 startingPage "547" @default.
• W2049166118 abstract "Since 2010, several new treatments for prostate cancer (PCa), which have entered the US market, are poised to have an impact on treatment approaches; however, there is a paucity of evidence with respect to treatment patterns and costs. As new treatment patterns emerge, it will be imperative to understand treatment patterns and costs of care prior to the advent of novel treatments.As the PCa treatment landscape is evolving, this study sought to compare the hospital-based utilization and costs in two cohorts of patients with PCa: patients with bone metastases (w/BM) and patients without bone metastases (w/oBM). Comparisons were also made for patients with inpatient versus outpatient encounters.Patients in the Premier Perspective Database, a US hospital database, between January 2006 and December 2010, treated in an inpatient or outpatient setting for PCa (International Classification of Diseases, 9th Revision [ICD-9] diagnosis codes 185, 233.4) were included. Patients were required to be ≥40 years of age with no additional cancers. Patients were put into cohorts on the basis of the presence of bone metastases (ICD-9 code 198.5 or use of zoledronic acid or pamidronate disodium). Utilization of PCa-related treatments was compared, controlling for age, race, hospital type, payer type, bed size, and admission source and type. Differences in treatments were assessed utilizing logistic regression, while differences in costs were analyzed using gamma-distributed generalized linear models with a log-link function. All costs are reported in US$ 2010.There were 23,747 hospitalizations for men w/BM (13,716 inpatient; 10,031 outpatient) and 187,708 hospitalizations (74,435 inpatient; 113,258 outpatient) for men w/oBM. The mean length of stay for men w/BM was 4 days compared with 2 days for men w/oBM (P < 0.0001). Overall, the mean cost per encounter was US$9,728 in men with w/BM and US$7,405 in men w/oBM (P = 0.0006). For inpatient stays, the mean cost per encounter was US$14,145 for men w/BM and US$11,944 for men w/oBM. For outpatient visits, the mean cost per encounter was US$3,688 for men w/BM and US$4,422 for men w/oBM. Men w/BM received hormone therapy (44.3%) and secondary hormone therapy (46.4%) most often, while men w/oBM received radiation (48.8%) and surgery (31.9%) most often.Costs and utilization of PCa-related treatments vary on the basis of the presence of metastases and treatment setting (inpatient vs. outpatient)." @default.
• W2049166118 created "2016-06-24" @default.
• W2049166118 creator A5000203747 @default.
• W2049166118 creator A5023313638 @default.
• W2049166118 creator A5032325756 @default.
• W2049166118 creator A5040067170 @default.
• W2049166118 creator A5046985026 @default.
• W2049166118 creator A5059381074 @default.
• W2049166118 creator A5066102500 @default.
• W2049166118 creator A5075945703 @default.
• W2049166118 creator A5084116267 @default.
• W2049166118 date "2014-07-09" @default.
• W2049166118 modified "2023-10-06" @default.
• W2049166118 title "Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases" @default.
• W2049166118 cites W1980238474 @default.
• W2049166118 cites W2005356522 @default.
• W2049166118 cites W2009616625 @default.
• W2049166118 cites W2057734107 @default.
• W2049166118 cites W2066723507 @default.
• W2049166118 cites W2103959341 @default.
• W2049166118 cites W2110534364 @default.
• W2049166118 cites W2113746964 @default.
• W2049166118 cites W2123526148 @default.
• W2049166118 cites W2132019398 @default.
• W2049166118 cites W2139110501 @default.
• W2049166118 cites W2148643283 @default.
• W2049166118 cites W2158639339 @default.
• W2049166118 cites W2165948908 @default.
• W2049166118 cites W2167331614 @default.
• W2049166118 cites W4241848697 @default.
• W2049166118 doi "https://doi.org/10.1007/s40258-014-0101-1" @default.
• W2049166118 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4175039" @default.
• W2049166118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25005491" @default.
• W2049166118 hasPublicationYear "2014" @default.
• W2049166118 type Work @default.
• W2049166118 sameAs 2049166118 @default.
• W2049166118 citedByCount "16" @default.
• W2049166118 countsByYear W20491661182014 @default.
• W2049166118 countsByYear W20491661182015 @default.
• W2049166118 countsByYear W20491661182016 @default.
• W2049166118 countsByYear W20491661182017 @default.
• W2049166118 countsByYear W20491661182019 @default.
• W2049166118 countsByYear W20491661182021 @default.
• W2049166118 countsByYear W20491661182022 @default.
• W2049166118 crossrefType "journal-article" @default.
• W2049166118 hasAuthorship W2049166118A5000203747 @default.
• W2049166118 hasAuthorship W2049166118A5023313638 @default.
• W2049166118 hasAuthorship W2049166118A5032325756 @default.
• W2049166118 hasAuthorship W2049166118A5040067170 @default.
• W2049166118 hasAuthorship W2049166118A5046985026 @default.
• W2049166118 hasAuthorship W2049166118A5059381074 @default.
• W2049166118 hasAuthorship W2049166118A5066102500 @default.
• W2049166118 hasAuthorship W2049166118A5075945703 @default.
• W2049166118 hasAuthorship W2049166118A5084116267 @default.
• W2049166118 hasBestOaLocation W20491661181 @default.
• W2049166118 hasConcept C121608353 @default.
• W2049166118 hasConcept C126322002 @default.
• W2049166118 hasConcept C137992405 @default.
• W2049166118 hasConcept C138816342 @default.
• W2049166118 hasConcept C142724271 @default.
• W2049166118 hasConcept C151956035 @default.
• W2049166118 hasConcept C194828623 @default.
• W2049166118 hasConcept C2776326535 @default.
• W2049166118 hasConcept C2777783956 @default.
• W2049166118 hasConcept C2780192828 @default.
• W2049166118 hasConcept C2908647359 @default.
• W2049166118 hasConcept C45827449 @default.
• W2049166118 hasConcept C524218345 @default.
• W2049166118 hasConcept C71924100 @default.
• W2049166118 hasConcept C99454951 @default.
• W2049166118 hasConceptScore W2049166118C121608353 @default.
• W2049166118 hasConceptScore W2049166118C126322002 @default.
• W2049166118 hasConceptScore W2049166118C137992405 @default.
• W2049166118 hasConceptScore W2049166118C138816342 @default.
• W2049166118 hasConceptScore W2049166118C142724271 @default.
• W2049166118 hasConceptScore W2049166118C151956035 @default.
• W2049166118 hasConceptScore W2049166118C194828623 @default.
• W2049166118 hasConceptScore W2049166118C2776326535 @default.
• W2049166118 hasConceptScore W2049166118C2777783956 @default.
• W2049166118 hasConceptScore W2049166118C2780192828 @default.
• W2049166118 hasConceptScore W2049166118C2908647359 @default.
• W2049166118 hasConceptScore W2049166118C45827449 @default.
• W2049166118 hasConceptScore W2049166118C524218345 @default.
• W2049166118 hasConceptScore W2049166118C71924100 @default.
• W2049166118 hasConceptScore W2049166118C99454951 @default.
• W2049166118 hasIssue "5" @default.
• W2049166118 hasLocation W20491661181 @default.
• W2049166118 hasLocation W20491661182 @default.
• W2049166118 hasLocation W20491661183 @default.
• W2049166118 hasLocation W20491661184 @default.
• W2049166118 hasLocation W20491661185 @default.
• W2049166118 hasOpenAccess W2049166118 @default.
• W2049166118 hasPrimaryLocation W20491661181 @default.
• W2049166118 hasRelatedWork W1856092259 @default.
• W2049166118 hasRelatedWork W1988873325 @default.
• W2049166118 hasRelatedWork W2016403587 @default.
• W2049166118 hasRelatedWork W2059755938 @default.
• W2049166118 hasRelatedWork W2187571762 @default.

• next